In this episode, I’m joined by Dr. Ian Ellis, a board-certified emergency medicine physician who believes we may be approaching GLP-1 dosing the wrong way.
Instead of automatically escalating patients toward higher and higher doses, Dr. Ellis focuses on finding each person’s individual therapeutic window — enough medication to make weight loss possible, without suppressing appetite to the point where eating, exercising and getting adequate nutrition become difficult.
We talk about why more medication doesn’t necessarily mean better results, side effects, muscle loss, semaglutide vs. tirzepatide, maintenance and whether everyone really needs to stay on GLP-1 medication for life. Ian also shares his own experience with obesity and semaglutide — and how that eventually led him to develop a mathematical approach to precision dosing and an app designed to help clinicians individualize treatment.
A fascinating conversation about moving away from “What dose are you on?” and toward a much more important question: “What dose actually works for you?”
","author_name":"The Weight Medicine Podcast"}